Inventor · disambiguated record
Hein K. A. C. Coolen
Also filed as: COOLEN HEIN K A C
17 granted patents·33 citations·filing 2002–2020
90Inventor score
Top patents by PatentIndex Score
17 records- 0184US10807991B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE BV·Filed 2018·Granted Oct 20, 2020·2 cites·9 claims
- 0284US8252930B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSTOIT AXEL·Filed 2010·Granted Aug 28, 2012·9 cites·4 claims
- 0383US9951084B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE BV·Filed 2016·Granted Apr 24, 2018·4 cites·10 claims
- 0477US8796262B2Fused heterocyclic derivatives as S1P modulatorsSMID PIETER·Filed 2011·Granted Aug 5, 2014·5 cites·31 claims
- 0576US10179791B2Spiro-cyclic amine derivatives as S1P modulatorsSTOIT AXEL·Filed 2011·Granted Jan 15, 2019·3 cites·22 claims
- 0676US9670220B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2015·Granted Jun 6, 2017·2 cites·24 claims
- 0775US7964728B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·2 cites·7 claims
- 0873US9096612B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2013·Granted Aug 4, 2015·2 cites·22 claims
- 0968US11427598B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE DEUTSCHLAND·Filed 2020·Granted Aug 30, 2022·0 cites·10 claims
- 1066US8084473B2Heterocyclic compounds with affinity to muscarinic receptorsSTOIT AXEL·Filed 2008·Granted Dec 27, 2011·0 cites·15 claims
- 1163US7202238B2Diazabicyclo alkane derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Apr 10, 2007·4 cites·6 claims
- 1257US8586606B2Heterocyclic compounds with affinity to muscarinic receptorsSTOIT AXEL·Filed 2011·Granted Nov 19, 2013·0 cites·12 claims
- 1355US8735388B2Heterocyclic compounds with affinity to muscarinic receptorsTERWEL LOUISE·Filed 2013·Granted May 27, 2014·0 cites·12 claims
- 1439USRE48301EFused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2011·Granted Nov 10, 2020·0 cites·39 claims
- 1538US7094779B2Piperazine oxime dervatives having NK-1 receptor antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Aug 22, 2006·0 cites·7 claims
- 1636US9045441B2(Thio)morpholine derivatives as S1P modulatorsIWEMA BAKKER WOUTER I·Filed 2010·Granted Jun 2, 2015·0 cites·20 claims
- 1732US9273017B2(Thio)morpholine derivatives as S1P modulatorsABBVIE BAHAMAS LTD·Filed 2015·Granted Mar 1, 2016·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →